Research Snappy
  • Market Research Forum
  • Investment Research
  • Consumer Research
  • More
    • Advertising Research
    • Healthcare Research
    • Data Analysis
    • Top Companies
    • Latest News
No Result
View All Result
Research Snappy
No Result
View All Result

Predicting Response to CRT Upgrade in Patients With Chronic Right Ventricular Pacing

researchsnappy by researchsnappy
January 30, 2021
in Healthcare Research
0
Predicting Response to CRT Upgrade in Patients With Chronic Right Ventricular Pacing
399
SHARES
2.3k
VIEWS
Share on FacebookShare on Twitter

Underlying heart disease and use of angiotensin-converting enzyme (ACE) inhibitors were found to be significant predictors of response to cardiac resynchronization therapy (CRT) upgrade in patients with chronic right ventricular pacing (RVP), according to a study published in Clinical Research in Cardiology.

In this study, 114 patients (mean age, 72.5 years; 77.2% men) with symptomatic heart failure and reduced left ventricular ejection fraction who had received a CRT upgrade in the previous 3 to 6 months due to frequent RVP (>50%) and were enrolled. In this cohort, the mean New York Heart Association (NYHA) class was 2.93 before implantation, and 78.1% of patients were NYHA class III. Improvement in NYHA class referring to the Minnesota Living With Heart Failure Questionnaire indicated response to CRT.

A linear regression model indicated that cardiomyopathy type and use of ACE inhibitors were the only factors to have an impact on the response to CRT upgrade. Patients with nonischemic cardiomyopathy (NICM) vs ischemic cardiomyopathy (ICM) had a greater responder rate (80.4 vs 60.3%, respectively, P <.05). In a univariate analysis, older age and elevated creatinine and potassium levels were associated with worse outcomes.

Study limitations include the fact that the definition of CRT response was solely based on clinical improvement on the validated Heart Failure Questionnaire, and may have been overestimated owing to the placebo effect. Also, the addition of solid echocardiographic parameters to the definition of response would have yielded further information on the effect of CRT.

“Response prediction in [patients receiving] CRT upgrade due to frequent or permanent RVP remains difficult,” noted the researchers. “Only type of underlying cardiomyopathy and use of ACE inhibitor had a significant influence on CRT response with a favorable outcome of NICM compared [with] ICM. Other traditional factors in the novo CRT population like female gender or QRS width do not appear to apply to [patients with] RVP. Especially the 200-ms threshold for inclusion of chronic paced patients in past CRT trials should be reconsidered. As long as the RVP is above 50%, the exact pacing burden does not seem to have a significant effect on CRT response. An exact cut-off value for CRT upgrade response needs still to be determined.”

Reference

Rath B, Willy K, Wolfes J, et al. Predictors of response to cardiac resynchronization therapy in patients with chronic right ventricular pacing [published online December 15, 2020]. Clin Res Cardiol. doi: 10.1007/s00392-020-01785-9

Topics:

Cardiomyopathy
Heart Failure

Previous Post

New research highlights racial disparities in the workforce in Seattle and makes actionable recommendations for equitable economic recovery

Next Post

Overworked teachers call for clarity and collaboration, new study finds - FE News

Next Post
Overworked teachers call for clarity and collaboration, new study finds – FE News

Overworked teachers call for clarity and collaboration, new study finds - FE News

Research Snappy

Category

  • Advertising Research
  • Consumer Research
  • Data Analysis
  • Healthcare Research
  • Investment Research
  • News

Cloud Applications Market consumer research – The Bisouv Network

Which plastic bottle size is worst for the environment? Study reveals a surprising answer

LSU students form The Cooperation Party for national public relations competition | News

  • Privacy Policy
  • Terms of Use
  • Antispam
  • DMCA
  • Contact Us

© 2021 researchsnappy.com

No Result
View All Result
  • Market Research Forum
  • Investment Research
  • Consumer Research
  • More
    • Advertising Research
    • Healthcare Research
    • Data Analysis
    • Top Companies
    • Latest News

© 2021 researchsnappy.com